BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27565220)

  • 1. Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats.
    Cobos-Puc LE; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2016 Nov; 791():25-36. PubMed ID: 27565220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats.
    Rubio-Beltrán E; Labastida-Ramírez A; Hernández-Abreu O; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2017 Oct; 812():97-103. PubMed ID: 28694067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats.
    Cobos-Puc LE; Villalón CM; Ramírez-Rosas MB; Sánchez-López A; Lozano-Cuenca J; Gómez-Díaz B; MaassenVanDenBrink A; Centurión D
    Eur J Pharmacol; 2009 Aug; 616(1-3):175-82. PubMed ID: 19527708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α2A-adrenoceptors, but not nitric oxide, mediate the peripheral cardiac sympatho-inhibition of moxonidine.
    Cobos-Puc LE; Aguayo-Morales H; Silva-Belmares Y; González-Zavala MA; Centurión D
    Eur J Pharmacol; 2016 Jul; 782():35-43. PubMed ID: 27112661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further analysis of the inhibition by agmatine on the cardiac sympathetic outflow: Role of the α
    Cobos-Puc L; Aguayo-Morales H; Ventura-Sobrevilla J; Luque-Contreras D; Chin-Chan M
    Eur J Pharmacol; 2017 Jun; 805():75-83. PubMed ID: 28315344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for the role of histamine H3, but not H1, H2 or H4, receptors in immepip-induced inhibition of the rat cardioaccelerator sympathetic outflow.
    Pinacho-García M; Marichal-Cancino BA; Villalón CM
    Eur J Pharmacol; 2016 Feb; 773():85-92. PubMed ID: 26826593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
    Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM
    Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evidence that alpha2A- and alpha2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats.
    Cobos-Puc LE; Villalón CM; Sánchez-López A; Lozano-Cuenca J; Pertz HH; Görnemann T; Centurión D
    Eur J Pharmacol; 2007 Jan; 554(2-3):205-11. PubMed ID: 17109851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
    Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G
    Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evidence that dopamine inhibits the cardioaccelerator sympathetic outflow via D2-like receptors in pithed rats.
    Alcántara-Vázquez O; Villamil-Hernández MT; Sánchez-López A; Centurión D
    J Pharmacol Sci; 2013; 123(4):380-91. PubMed ID: 24225403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of noradrenaline release in pithed spontaneously hypertensive rats by I1-binding sites in addition to alpha2-adrenoceptors.
    Raasch W; Jungbluth B; Schäfer U; Häuser W; Dominiak P
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1063-71. PubMed ID: 12604683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence that 5-HT1A/1B/1D, α2-adrenoceptors and D2-like receptors mediate ergotamine-induced inhibition of the vasopressor sympathetic outflow in pithed rats.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Gutiérrez-Lara EJ; Centurión D
    Eur J Pharmacol; 2014 Oct; 740():512-21. PubMed ID: 24975101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The α2-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with α2A, α2B and α2C subtypes.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2013 Oct; 718(1-3):245-52. PubMed ID: 24028939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence that metformin blocks the vasopressor responses mediated by stimulation of α
    de la Cruz SH; Medina-Terol GJ; Beltrán-Ornelas JH; Gomez CB; Morato-Valderrama Y; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2018 Feb; 820():130-137. PubMed ID: 29248426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptors.
    Schäfer U; Burgdorf C; Engelhardt A; Kurz T; Richardt G
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1163-70. PubMed ID: 12438540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norepinephrine release is reduced by I(1)-receptors in addition to alpha(2)-adrenoceptors.
    Raasch W; Jungbluth B; Schäfer U; Häuser W; Dominiak P
    Ann N Y Acad Sci; 2003 Dec; 1009():270-3. PubMed ID: 15028598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NaHS prejunctionally inhibits the cardioaccelerator sympathetic outflow in pithed rats.
    Centurión D; de la Cruz SH; Castillo-Santiago SV; Becerril-Chacón ME; Torres-Pérez JA; Sánchez-López A
    Eur J Pharmacol; 2018 Mar; 823():35-40. PubMed ID: 29378194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of moxonidine on the uveoscleral outflow: role of alpha2-adrenoceptors or i1 imidazoline receptors.
    Yang J; Sun N; Xiong Q; Yang R
    Curr Eye Res; 2009 Apr; 34(4):287-96. PubMed ID: 19373577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.